BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30520529)

  • 1. Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control Study.
    Cohn E; Lurie I; Yang YX; Bilker WB; Haynes K; Mamtani R; Shacham-Shmueli E; Margalit O; Boursi B
    J Trauma Stress; 2018 Dec; 31(6):919-926. PubMed ID: 30520529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent antibiotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota?
    Boursi B; Mamtani R; Haynes K; Yang YX
    Eur J Cancer; 2015 Nov; 51(17):2655-64. PubMed ID: 26338196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum.
    Wang H; Rothenbacher D; Löw M; Stegmaier C; Brenner H; Diepgen TL
    Int J Cancer; 2006 Aug; 119(3):695-701. PubMed ID: 16506215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study.
    Gào X; Wilsgaard T; Jansen EHJM; Xuan Y; Anusruti A; Brenner H; Schöttker B
    Int J Cancer; 2020 Mar; 146(5):1261-1267. PubMed ID: 31125113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of ultra-processed foods and drinks and colorectal, breast, and prostate cancer.
    Romaguera D; Fernández-Barrés S; Gracia-Lavedán E; Vendrell E; Azpiri M; Ruiz-Moreno E; Martín V; Gómez-Acebo I; Obón M; Molinuevo A; Fresán U; Molina-Barceló A; Olmedo-Requena R; Tardón A; Alguacil J; Solans M; Huerta JM; Ruiz-Dominguez JM; Aragonés N; Fernández-Villa T; Dierssen-Sotos T; Moreno V; Guevara M; Vanaclocha-Espi M; Lozano-Lorca M; Fernández-Tardón G; Castaño-Vinyals G; Pérez-Gómez B; Molina AJ; Llorca J; Gil L; Castilla J; Pollán M; Kogevinas M; Amiano P
    Clin Nutr; 2021 Apr; 40(4):1537-1545. PubMed ID: 33743289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer incidence in Israeli Jewish survivors of World War II.
    Keinan-Boker L; Vin-Raviv N; Liphshitz I; Linn S; Barchana M
    J Natl Cancer Inst; 2009 Nov; 101(21):1489-500. PubMed ID: 19861305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States.
    Coghill AE; Engels EA; Schymura MJ; Mahale P; Shiels MS
    J Natl Cancer Inst; 2018 Sep; 110(9):959-966. PubMed ID: 29529223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic blockers and the risk for common solid cancers: a case-control study.
    Numbere B; Fleming KM; Walker A; Card TR
    Eur J Cancer Prev; 2017 Jan; 26(1):86-93. PubMed ID: 26649549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.
    Hippisley-Cox J; Vinogradova Y; Coupland C; Parker C
    Arch Gen Psychiatry; 2007 Dec; 64(12):1368-76. PubMed ID: 18056544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary 8-isoprostane levels and occurrence of lung, colorectal, prostate, breast and overall cancer: Results from a large, population-based cohort study with 14 years of follow-up.
    Gào X; Brenner H; Holleczek B; Cuk K; Zhang Y; Anusruti A; Xuan Y; Xu Y; Schöttker B
    Free Radic Biol Med; 2018 Aug; 123():20-26. PubMed ID: 29778463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-diagnostic derivatives of reactive oxygen metabolites and the occurrence of lung, colorectal, breast and prostate cancer: An individual participant data meta-analysis of two large population-based studies.
    Gào X; Wilsgaard T; Jansen EH; Holleczek B; Zhang Y; Xuan Y; Anusruti A; Brenner H; Schöttker B
    Int J Cancer; 2019 Jul; 145(1):49-57. PubMed ID: 30561010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.
    Ram P; Tiu A; Lo KB; Parikh K; Shah M
    Heart Fail Rev; 2019 Nov; 24(6):989-995. PubMed ID: 31175492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
    Sturgeon SR; Pilsner JR; Arcaro KF; Ikuma K; Wu H; Kim SM; Chopra-Tandon N; Karpf AR; Ziegler RG; Schairer C; Balasubramanian R; Reckhow DA
    Breast Cancer Res; 2017 Aug; 19(1):94. PubMed ID: 28821281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
    Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
    Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116,000 European men and women.
    Heikkilä K; Nyberg ST; Theorell T; Fransson EI; Alfredsson L; Bjorner JB; Bonenfant S; Borritz M; Bouillon K; Burr H; Dragano N; Geuskens GA; Goldberg M; Hamer M; Hooftman WE; Houtman IL; Joensuu M; Knutsson A; Koskenvuo M; Koskinen A; Kouvonen A; Madsen IE; Magnusson Hanson LL; Marmot MG; Nielsen ML; Nordin M; Oksanen T; Pentti J; Salo P; Rugulies R; Steptoe A; Suominen S; Vahtera J; Virtanen M; Väänänen A; Westerholm P; Westerlund H; Zins M; Ferrie JE; Singh-Manoux A; Batty GD; Kivimäki M;
    BMJ; 2013 Feb; 346():f165. PubMed ID: 23393080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study.
    Hálfdánarson ÓÖ; Fall K; Ogmundsdottir MH; Lund SH; Steingrímsson E; Ogmundsdottir HM; Zoega H
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):471-478. PubMed ID: 30565786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
    Laitinen VH; Wahlfors T; Saaristo L; Rantapero T; Pelttari LM; Kilpivaara O; Laasanen SL; Kallioniemi A; Nevanlinna H; Aaltonen L; Vessella RL; Auvinen A; Visakorpi T; Tammela TL; Schleutker J
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):452-60. PubMed ID: 23292082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on potential associations of oxidatively generated DNA/RNA damage with lung, colorectal, breast, prostate and total cancer incidence.
    Gào X; Holleczek B; Cuk K; Zhang Y; Anusruti A; Xuan Y; Xu Y; Brenner H; Schöttker B
    Sci Rep; 2019 May; 9(1):7109. PubMed ID: 31068619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk.
    Boursi B; Haynes K; Mamtani R; Yang YX
    J Natl Cancer Inst; 2015 Jun; 107(6):djv084. PubMed ID: 25855726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.